Mark J. Newman Ph.D.
Net Worth

Last updated:

What is Mark J. Newman Ph.D. net worth?

The estimated net worth of Dr. Mark J. Newman Ph.D. is at least $2,056,935 as of 11 Jun 2010. He owns shares worth $735 as insider and has received compensation worth at least $2,056,200 in GeoVax Labs, Inc..

What is the salary of Mark J. Newman Ph.D.?

Dr. Mark J. Newman Ph.D. salary is $137,080 per year as Chief Scientific Officer in GeoVax Labs, Inc..

How old is Mark J. Newman Ph.D.?

Dr. Mark J. Newman Ph.D. is 70 years old, born in 1955.

What stocks does Mark J. Newman Ph.D. currently own?

As insider, Dr. Mark J. Newman Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
GeoVax Labs, Inc. (GOVX) Chief Scientific Officer 1,000 $0.73 $735

What does GeoVax Labs, Inc. do?

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S. Department of Defense; Emory University; University of Pittsburgh; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Mark J. Newman Ph.D. insider trading

GeoVax Labs, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 3,000 $3.29 $9,855

GeoVax Labs key executives

GeoVax Labs, Inc. executives and other stock owners filed with the SEC: